What is CVE-2026-100717?

CVE-2026-100717 is froxlor before 2.3.12 CRLF Injection via validateUrl userinfo. The supplied enrichment data classifies it as Injection mapped to CWE-93 CWE-93.

Which versions are affected?

Affected product and version evidence is listed in the product table above. Current public advisories should be checked for exact version scope before patch targeting is finalized.

Is there active exploitation?

Active exploitation is not confirmed from current sources for CVE-2026-100717. If exploitation is not confirmed from current sources, teams should document that status and continue monitoring KEV, vendor, and telemetry updates.

No. CVE-2026-100717 is not listed in CISA KEV in the supplied enrichment data. KEV status should be monitored because it can change after initial disclosure or after exploitation becomes publicly confirmed.

Is there a public exploit?

2 public PoC repositories reported; 0 marked weaponized in current dataset. Public exploit or PoC availability should raise triage priority, especially for exposed or business-critical systems.

How can defenders detect it?

Start with web/proxy/WAF logs, application logs, network IDS/IPS, database audit logs where available. Look for vulnerability-class behavior, product errors, suspicious authentication events, exploit probes, and abnormal process activity based only on evidence that applies to the affected product.

How should teams prioritize it?

Prioritize CVE-2026-100717 using CVSS 9.9, EPSS 0%, KEV status, public PoC status, and asset exposure. Internet-facing, privileged, or business-critical deployments should be handled first.

Are workarounds available?

The supplied mitigation guidance says to apply vendor patches and restrict external exposure until fixed. Fixed-version evidence is listed in the mitigation section above.

Which threat actors are linked publicly?

No public threat actor linkage is confirmed from current sources. Do not attribute exploitation to a threat actor unless the source evidence explicitly supports that linkage.

What should be done in the next 24 hours?

Identify exposed assets running affected vendor/product/version combinations. Prioritize based on EPSS, PoC availability, and external exposure. Search available logs for exploit probes, errors, authentication anomalies, or suspicious child processes matching the vulnerability class. Open remediation tickets with affected assets, owners, evidence status, and detection coverage so decisions are traceable.

criticalInjectionpublic exploit

CVE-2026-100717

CVE-2026-100717 — froxlor before 2.3.12 CRLF Injection via validateUrl userinfo

froxlor is a server administration panel. In versions 2.3.10 and earlier, Validate::validateUrl rejects carriage return and line feed characters only in the path, query and fragment components returned by parse_url, and never inspects the userinfo (user:pass@) components. This is an incomplete fix for GHSA-c3p2. An authenticated low-privilege customer with subdomain-create rights (no admin or change_serversettings privilege required) can supply a subdomain redirect URL that carries a CR/LF payload in the userinfo portion (e.g. http://user%0areturn 200 "pwned";%[email protected]/). The value passes validation, survives IDNA encoding, and is written verbatim into the generated nginx or Apache vhost configuration, allowing the attacker to break out of the emitted directive and inject arbitrary web-server configuration lines. froxlor regenerates and reloads the web-server configuration as root, so the injected directives take effect server-wide and can hijack responses or read local files. The issue is fixed in version 2.3.12.

Published Sep 26, 2026Updated Sep 26, 2026Sources: NVD, froxlor (CNA), GitHub

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the scoring sources call it.

Exploitation

Exploit code

public exploit, none observed

EPSS

Not scored

FIRST has not published a score

Affects

froxlor

2 products listed

CVSS base

9.9

critical · 2 sources

Remediation

The vendor's own words where we have them.

Upgrade froxlor to a fixed release (2.3.12). Apply vendor patches per advisory and restrict external exposure of the affected component until patched.

First 24 hours

Ordered from the record's own fields — exposure first, because you cannot patch what you have not found.

Identify exposed assets running affected vendor/product/version combinations.
Prioritize based on EPSS, PoC availability, and external exposure.
Search available logs for exploit probes, errors, authentication anomalies, or suspicious child processes matching the vulnerability class.

Affected scope

Vendor, product and version as the advisories word them.

Vendor	Product	Versions	Status
froxlor	froxlor	0 to < 2.3.12	Vulnerable
froxlor	froxlor	2.3.12	Patched

Attack characteristics

The CVSS vector, decoded. It describes the attack, not your exposure to it.

Availability

High

Confidentiality

Low

Integrity

High

Scope

Changed

Attack Complexity

Low

Attack Vector

Network

Privileges Req

Low

User Interaction

None

Every base score collected

Sources score independently and disagree; each row says who scored it and under which version.

Score	Version	Severity	Expl.	Impact	Source
9.9	CVSS 3.1	critical	3.1	6	NVD, froxlor (CNA)
8.5	CVSS 4.0	high	—	—	froxlor (CNA)

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:H

Weakness & attack patterns

CWE-93

Inferred from the weakness class — not observed against this CVE.

CAPEC-66 · SQL InjectionCAPEC-7 · Blind SQL Injection

Public exploit

Capability, not use: code existing is a different claim from anyone running it.

Repositories

Detection

Read off the CVSS vector and the weakness class. Starting points, not rules we have tested.

Search application, proxy, and WAF logs for requests touching /LF, //user%0areturn, /).
Prioritize edge telemetry for network-reachable froxlor.
Monitor for scanner or exploit-pattern traffic after 2 public PoC repositories were reported.

web/proxy/WAF logsapplication logsnetwork IDS/IPSdatabase audit logs

Timeline

What happened to this CVE, newest first — with the readings a source repeats on a schedule counted underneath rather than listed.

2026
Added · CVSS 3.1 9.9 (AV:N)
Sep 26, 2026 · NVD
Initial · CVE published
Sep 26, 2026 · NVD

References

2 on the record

github.com/froxlor/froxlor/security/advisories/GHSA-gxx3-hwjc-h2gp
Exploit, Third Party Advisory
www.vulncheck.com/advisories/froxlor-before-2.3.12-crlf-injection-via-validateurl-userinfo
Vendor Advisory

Elsewhere on this site

froxlorevery CVE for this vendor
Injectionsame class
CWE-93other pages naming this weakness

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
No exploit packet captures, log samples, or incident case IDs supplied.

Answered from this record1

What should defenders know first?

CVE-2026-100717 is froxlor before 2.3.12 CRLF Injection via validateUrl userinfo, a critical vulnerability affecting froxlor from froxlor. The current evidence does not list it in CISA KEV, and the exploit status is: Active exploitation is not confirmed from current sources for CVE-2026-100717. Public exploit evidence is: 2 public PoC repositories reported; 0 marked weaponized in current dataset. The affected-version evidence is listed in the key facts and affected products tables. Defenders should first verify whether exposed or business-critical assets run those versions, then apply vendor patches or mitigations, restrict reachable attack surface, and preserve logs for detection review. CVSS 9.9 describes technical severity, while EPSS 0% helps estimate near-term exploit likelihood; neither replaces asset context. Unknown fields should remain explicit in tickets, and threat actor, IOC, victimology, or payload claims should not be added unless a cited source supports them. Monitor CISA KEV, vendor advisories, NVD changes, public PoC repositories, and internal telemetry for update triggers.